Estimation of primary care treatment costs and treatment efficacy for people with Type 1 and Type 2 diabetes in the United Kingdom from 1997 to 2007

Diabetic Medicine

Volumn 27, Issue 8, 2010, Pages 938-948

  Currie, C J ^a   Gale, E A M ^b   Poole, C D ^c  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c Worldwide Epidemiology   (United Kingdom)

Author keywords

cost effectiveness; diabetes; prescribing; resource use; trend

Indexed keywords

HEMOGLOBIN A1C; INSULIN; LIPID; METFORMIN; SULFONYLUREA DERIVATIVE;

ADULT; ARTICLE; BLOOD PRESSURE; CONSULTATION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DIABETIC PATIENT; FEMALE; HEALTH CARE COST; HEALTH CARE FINANCING; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRESCRIPTION; PRIMARY MEDICAL CARE; RETROSPECTIVE STUDY; UNITED KINGDOM;

ADOLESCENT; COST-BENEFIT ANALYSIS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; GREAT BRITAIN; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE;

EID: 77954766619     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2010.03040.x     Document Type: Article

References (25)

1. Currie CJ, Kraus D, Morgan CL, Gill L, Stott NCH, Peters JR. NHS acute sector expenditure for diabetes: the present, future, and excess in-patient cost of care. Diabet Med 1997 14 : 686 692.
2. Bagust A, Hopkinson P, Maslove L, Currie CJ. The projected health care burden of Type 2 diabetes in the UK from 2000 to 2060. Diabet Med 2002 19 (Suppl 4 1 5.
3. Morgan CL, Peters JR, Dixon S, Currie CJ. Estimated costs of acute hospital care for people with diabetes in the United Kingdom: a routine record linkage study in a large region. Diabet Med under review CL, Peters JR, Currie CJ. The changing prevalence of diagnosed diabetes and its associated vascular complications in a health district of the United Kingdom. Diabet Med, 2010 27 : 673 678.
4. Currie CJ, Peters JR, Evans M. Dispensing patterns and financial costs of glucose lowering therapies in the United Kingdom from 2000 to 2008. Diabet Med, 2010 27 : 744 752.
5. Gelfand JM, Margolis DJ, Dattani H. The UK General Practice Research Database. In Pharmacoepidemiology (3rd edn). Strom BL (ed). Wiley
6. Jick H, Jick SS. Validation of information recorded on general practitioner based computerized data resource in the United Kingdom. Br Med J 1991 302 : 766 768.
7. Lewis JD, Shinnar R, Bilker W, Wang X, Strom BL. Validation studies of the health improvement network for pharmacoepidemiology studies. Pharmacoepidemiol Drug Saf 2007 16 : 393 401.
8. General Practice Research Database. Available at http://www.gprd.com/home Last accessed 17 September 2007.
9. The General Practice Research Database: information for researchers.
10. Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006 55 : 829 835. (Pubitemid 44556851)
11. Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA 2006 296 : 1735 1741. (Pubitemid 44547793)
12. Burke TA, Sturkenboom MC, Ohman-Strickland PA, Wentworth CE, Rhoads GG. The effect of antihypertensive drugs and drug combinations on the incidence of new-onset type-2 diabetes mellitus. Pharmacoepidemiology and Drug Safety 2007 16 : 979 987.
13. Mulnier HE, Seaman HE, Raleigh VS, Soedamah-Muthu SS, Colhoun HM, Lawrenson RA. Mortality in people with type 2 diabetes in the UK. Diabet Med 2006 23 : 516 521.
14. Margolis DJ, Hoffstad O, Strom BL. Association between serious ischemic cardiac outcomes and medications used to treat diabetes. Pharmacoepidemiol Drug Saf 2008 17 : 753 759.
15. Currie CJ, Poole CD, Gale EAM. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia 2009 52 : 1766 1777.
16. NHS Information Centre. Available at http://www.ic.nhs.uk/statistics-and- data-collections/primary-care/prescriptions Last accessed 14 July 2009.
17. Her Majesty's Treasury. Available at http://www.hm-treasury.gov.uk/data- gdp-fig.htm Last accessed 14 July 2009.
18. Curtis L. Unit Costs of Health and Social Care. 2007. University of Kent
19. Anonymous. Prescribing for Diabetes in England: An Update 2002-2008.
20. Rosenstock J, Fonseca V, McGill JB, Riddle M, Hallé J-P, Hramiak I et al. Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study. Diabetologia 2009 52 : 1778 1788.
21. 1c findings. Diabetologia 2009 52 : 2234 2235.
22. Anonymous. National Diabetes Audit.
23. Evans M, Poole CD, Smith HT, Simpson A, Peters JR, Tynan A et al. Characterization of insulin initiation in type 2 diabetes in UK general practice: guidelines in perspective. Available at http://professional.diabetes. org/Abstracts-Display.aspx?TYP=1&CID=69875 Last accessed 14 July 2009.
24. Currie CJ, Peters JR, Tynan A, Evans M, Heine RJ, Bracco OL et al. Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. LANCET 2010 375 : 481 489.
25. Ott A, Stolk RP, van Harskamp F, Pols HAP, Hofman A, Breteler M. Diabetes mellitus and the risk of dementia: the Rotterdam Study. Neurology 1999 53 : 1937 1942.